CXCR2 and neoplasm: Thus, we constructed the orthotopic KPC model and administered the CXCR2 inhibitor (SB225002), AB680+anti‐PD‐1 therapy, or a combination of those drugs 3 days after tumor transplantation (Figure 7A).